What does POST mean?
POST means potassium-channel opening stroke trial
This acronym/slang usually belongs to Medical & Science category.
What is the abbreviation for potassium-channel opening stroke trial?
potassium-channel opening stroke trial can be abbreviated as POST
|
|
Most popular questions people look for before coming to this page
Q: A: |
What does POST stand for? POST stands for "potassium-channel opening stroke trial". |
Q: A: |
How to abbreviate "potassium-channel opening stroke trial"? "potassium-channel opening stroke trial" can be abbreviated as POST. |
Q: A: |
What is the meaning of POST abbreviation? The meaning of POST abbreviation is "potassium-channel opening stroke trial". |
Q: A: |
What is POST abbreviation? One of the definitions of POST is "potassium-channel opening stroke trial". |
Q: A: |
What does POST mean? POST as abbreviation means "potassium-channel opening stroke trial". |
Q: A: |
What is shorthand of potassium-channel opening stroke trial? The most common shorthand of "potassium-channel opening stroke trial" is POST. |
Abbreviations or Slang with similar meaning
- HAEST - Heparin in Acute Embolic Stroke Trial
- INWEST - Intravenous Nimodipine West European Stroke Trial
- KCNQ - Potassium Channel, Voltage-Gated, KQT-like subfamily
- KVLQT - Potassium Channel, Voltage-Gated, KQT-Like Subfamily
- MAHST - Multicenter Austrian Hemodilution Stroke Trial
- CAST - Chinese Acute Stroke Trial
- IRPC - Inwardly Rectifying Potassium Channel
- KCNA - Potassium Channel, Voltage-Gated, Shaker-Related Subfamily
- SCAST - Scandinavian Candesartan Acute Stroke Trial
- SNEPCO - Selective Neuronal Potassium Channel Opener
- TAIST - Tinzaparin in Acute Ischaemic Stroke Trial
- BK - potassium channel
- BKCA - calcium-activated potassium channel
- EST - Early Stroke Trial
- FIRST - Families in Recovery from Stroke Trial
- PCA - Potassium Channel Agonists
- PCO - potassium channel opener
- Pcos - Potassium Channel Openers
- TOAST - Treatment of Acute Stroke Trial
- NINDS-TPAST - National Institute Of Neurological Disorders And Stroke-Tissue Plasminogen Activator Stroke Trial